The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.

  title={The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.},
  author={Mara Sanches Guaragna and Fernanda Caroline Soardi and Juliana Godoy Assumpç{\~a}o and L J G Zambaldi and Izilda Aparecida Cardinalli and Jos{\'e} Andr{\'e}s Yunes and Maricilda Palandi de Mello and S{\'i}lvia Regina Brandalise and Simone dos Santos Aguiar},
  journal={Journal of pediatric hematology/oncology},
  volume={32 6},
SUMMARY Denys-Drash syndrome (DDS, Online Mendelian Inheritance in Man number 194080) is a rare human developmental disease generally occurring in 46,XY individuals characterized by the combination of disorder of sex development, early onset nephropathy, and Wilms' tumor (WT). DDS is mainly caused by mutations in the WT1 gene. This report describes a novel WT1 gene mutation in a DDS patient. Sequencing the WT1 gene revealed a heterozygous transversion CAT>AAT within exon 8, causing the… Expand
Clinical Pictures and Novel Mutations of WT1-Associated Denys–Drash Syndrome in Two Chinese Children
A de novo mutation in WT1 truncates 60 amino acids at the C terminus, and it is predicted to result in loss of the DNA-binding capacities of the WT1 protein. Expand
Genetics Home Reference Your Guide to Understanding Genetic Conditions COL 1 A 1 gene collagen type I alpha 1 chain Normal Function
A particular mutation in the COL1A1 gene causes infantile cortical hyperostosis, commonly known as Caffey disease. The signs and symptoms of Caffey disease are usually apparent by the time an infantExpand
Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy
This case highlights a very early presentation of bilateral GB in DDS and the consideration of early prophylactic gonadectomy at the time of diagnosis with DDS. Expand
Denys‐Drash Syndrome
People with Denys-Drash syndrome have an estimated 90 percent chance of developing a rare form of kidney cancer known as Wilms tumor. Expand
Mitochondrial complex I deficiency
Mitochondrial complex I deficiency is a shortage (deficiency) of a protein complex called complex I or a loss of its function. Complex I is found in cell structures called mitochondria, which convertExpand
Index analysis and human health risk model application for evaluating ambient air-heavy metal contamination in Chemical Valley Sarnia.
Overall, children are more likely to develop carcinogenic and non-carcinogenic health effects from exposures to elemental concentrations of airborne PM in the study area, especially for the children in the area. Expand


WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin
Analysis of exons 2–10 of the WT1 gene in constitutional DNA from five patients with DDS showed heterozygous germline mutations were found, and polymorphic markers from the short arm of chromosome 11 were used to determine the parental origin of the mutant chromosome. Expand
Inherited WT1 mutation in Denys-Drash syndrome.
It is indicated that the WT1 exon 9 mutation affecting 394Arg demonstrated in over one-half of the patients with the Denys-Drash syndrome may exhibit incomplete penetrance, and familial studies in patients affected by this syndrome are recommended. Expand
The genomic organization and expression of the WT1 gene.
To facilitate the search for smaller deletions and point mutations, the genomic organization of the WT1 gene is established and the sequence of all 10 exons and flanking intron DNA is determined, forming the basis for future studies of mutant alleles at this locus. Expand
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
YTOGENETIC analysis has identified chromosome Ilpl3 as the smallest overlap region for deletions found in individuals with WAGR syndrome, which includes Wilms tumour, anirida, genito-urinary abnormalities and mental retardation. Expand
Wilms tumor and the WT1 gene.
Understanding the distinct functional properties of WT1 isoforms and tumor-associated variants will provide unique insight into the link between normal organ-specific differentiation and malignancy. Expand
Clinical and genetic findings of five patients with WT1-related disorders.
Constitutional abnormalities of WT1 cause gonadal and renal anomalies and predisposition to neoplasia and must be investigated in patients with ambiguous genitalia, chronic renal disease and(or) Wilms tumors; primary amenorrhea with Chronic renal disease; and aniridia, genital ambiguity and dysmorphisms. Expand
Regulation of Gene Expression by WT1 in Development and Tumorigenesis
  • L. Ellisen
  • Biology, Medicine
  • International journal of hematology
  • 2002
WT1-dependent functions are now more clearly linked to its property as a transcriptional activator of genes involved in renal development and sex determination, and a hematopoietic model system has been used to study functional properties of WT1 in vitro. Expand
The candidate Wilms' tumour gene is involved in genitourinary development
In situ messenger RNA hybridization on sections of human embryos and Wilms' tumours suggests that the associated genital abnormalities are pleiotropic effects of mutation in the Wilms’ tumour gene itself, in support of recent genetic analysis11. Expand
A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease.
This constellation of findings, reported only once previously, probably represents an intrauterine alteration of cellular differentiation, affecting renal, gonadal, and other internal and external sexual structures. Expand
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
The genetic localization of this gene, its tissue-specific expression, and the function predicted from its sequence lead us to suggest that it represents the 11p13 Wilms' tumor gene. Expand